Literature DB >> 10499788

Congenital syphilis--United States, 1998.

.   

Abstract

Congenital syphilis (CS) occurs when the spirochete Treponema pallidum is transmitted from a pregnant woman with syphilis to her fetus. A multiorgan infection, CS may result in a neurologic or musculoskeletal handicap or death in the fetus when not properly treated. Trends in CS rates in women of childbearing age follow by approximately 1 year the rates of primary and secondary syphilis. The last national syphilis epidemic, which was followed by a CS epidemic, occurred during the late 1980s and early 1990s. The syphilis rate began to decline in 1991; the CS rate began to decline in 1992. To evaluate CS epidemiology since this decline, CDC analyzed 1998 CS notifiable disease data and assessed rate changes during 1992-1998. This report summarizes the results, which indicate that the CS rate declined 78.2% from 1992 to 1998, and that rates remained disproportionately high in the southeastern United States and among minority racial/ethnic populations.

Entities:  

Mesh:

Year:  1999        PMID: 10499788

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

1.  A premature newborn with vesiculobullous skin lesions.

Authors:  Mehmet Vural; Barbaros Ilikkan; Erdal Polat; Tevfik Demir; Yildiz Perk
Journal:  Eur J Pediatr       Date:  2003-01-16       Impact factor: 3.183

2.  Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model.

Authors:  Cecilia A Morgan; Sheila A Lukehart; Wesley C Van Voorhis
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Brazilian Protocol for Sexually Transmitted Infections, 2020: congenital syphilis and child exposed to syphilis.

Authors:  Carmen Silvia Bruniera Domingues; Geraldo Duarte; Mauro Romero Leal Passos; Denise Cardoso das Neves Sztajnbok; Maria Luiza Bezerra Menezes
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.